Healthcare & Biotech

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor, a pulse oximetry device built around internal optical refinements that improve signal quality. In desaturation testing, the sensor posted an accuracy result nearly twice as tight as the level recommended by ISO and recognized by the FDA. It also held accuracy within half a percentage point between light and dark skin pigmentation groups tested. The clearance extends Philips' broader pulse oximetry portfolio and follows a validation program built specifically around performance across diverse patient populations.

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has launched Alturion, a new ultrasound system built for departments that run high patient volumes across varied exam types. The system pairs AI-powered workflow tools with imaging hardware designed to hold up across shift changes and multiple users. Alturion has received FDA 510(k) clearance and CE mark certification, making it available now in the U.S. and Europe. Philips positions the launch as an expansion of its ultrasound portfolio rather than a standalone product, built to share transducers and interface design with existing systems already in clinical use.

SHERIDAN, WYOMING -- July 07, 2026 -- Roche announced positive results from the phase III Krascendo 1 study, showing that its investigational KRAS G12C inhibitor divarasib outperformed the approved first-generation inhibitors sotorasib and adagrasib in patients with previously treated KRAS G12C non-small cell lung cancer. The study met both its primary and key secondary endpoints, with divarasib delivering statistically significant improvements in progression-free survival and overall survival. Roche plans to submit the data to health authorities and present full results at an upcoming medical meeting. The company positions the results as evidence that divarasib could become a new treatment standard for this genetically defined subgroup of lung cancer patients.

SHERIDAN, WYOMING -- June 25, 2026 -- Dentsply Sirona and HeyGears have announced the successful validation of Lucitone Digital Print Denture resins for one-piece denture production on HeyGears' new UltraCraft Multi-Material Fusion DLP 3D printer. The validation extends an existing collaboration between the two companies and establishes a production pathway that eliminates the bonding step previously required to attach Lucitone Digital IPN 3D denture teeth to the denture base. Dental laboratories using the combined workflow can now produce complete monolithic dentures in a single print run while maintaining the mechanical strength, esthetics, and durability associated with the Lucitone material platform. The announcement covers full-arch and partial denture applications.

SHERIDAN, WYOMING -- June 15, 2026 -- Dentsply Sirona has appointed John Fortson as Executive Vice President and Chief Financial Officer, effective July 20, 2026. Fortson joins from Kymera International, where he served as President and CFO, and brings more than 25 years of finance, operations, and strategy experience across global manufacturing and industrial businesses. The appointment is framed by the company as a key step in advancing its Return-to-Growth Action Plan.

SHERIDAN, WYOMING -- June 15, 2026 -- VOCO has become a Gold Sponsor of the FDI World Dental Federation, with the partnership centred on the FDI's Master Continuing Education Programme in adhesive and aesthetic dentistry. The five-module programme delivers specialised clinical training to dental professionals globally, combining theoretical content with practical application under guidance from established speakers in the field. VOCO's sponsorship includes both financial support and provision of composite materials for hands-on use during seminars.

SHERIDAN, WYOMING -- June 15, 2026 -- VOCO has introduced a range of fluorescent dental materials spanning temporary luting, temporary filling, core build-up, and aligner attachment workflows. The four products — Bifix Temp fluorescent, Clip F fluorescent, Rebilda DC fluorescent, and AlignerFlow LC — each carry UV-A-activated fluorescence that makes excess material and residues visible without altering aesthetics under natural light. The approach addresses a practical clinical problem: material residues that are difficult to detect with the naked eye but consequential for the quality of subsequent restorations and treatments.

SHERIDAN, WYOMING -- June 15, 2026 -- Roche has received FDA approval for the VENTANA PTEN (SP218) RxDx Assay, the first immunohistochemistry companion diagnostic cleared to assess PTEN protein loss in patients with prostate adenocarcinoma. The assay identifies patients whose tumours exhibit PTEN deficiency, making them potentially eligible for treatment with AstraZeneca's TRUQAP in combination with abiraterone acetate. Approval is based on results from the CAPItello-281 clinical study, where the assay served as the enrollment diagnostic to identify patients with PTEN-deficient tumours.

SHERIDAN, WYOMING -- June 15, 2026 -- The U.S. Food and Drug Administration has accepted Roche's supplemental Biologics License Application for Tecentriq and Tecentriq Hybreza in combination with chemotherapy as an adjuvant treatment for stage III dMMR/MSI-H colon cancer following surgery. The FDA has granted Priority Review and is expected to issue a decision by October 9, 2026. The filing is supported by Phase III ATOMIC study data showing a 50% reduction in the risk of disease recurrence or death compared to chemotherapy alone, results published in The New England Journal of Medicine.

SHERIDAN, WYOMING -- June 15, 2026 -- Dentsply Sirona has launched the WaveOne® Gold Orifice Shaper, its first reciprocating coronal flaring instrument, now available in the United States and Canada. The file is designed to integrate directly into the existing WaveOne® Gold treatment protocol, using the same reciprocating motion and motor settings as the rest of the system. That compatibility eliminates the need to change motor configurations during root canal preparation — a practical workflow improvement that reduces procedural complexity and the risk of operator error.